Global Serological Transplant Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Serological Transplant Diagnostics Market Growth (Status and Outlook) 2023-2029

Serological transplant diagnostics are used for all types of transplants. The products are developed based on the agglutination and complement fixation technology.

LPI (LP Information)' newest research report, the “Serological Transplant Diagnostics Industry Forecast” looks at past sales and reviews total world Serological Transplant Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Serological Transplant Diagnostics sales for 2023 through 2029. With Serological Transplant Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serological Transplant Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Serological Transplant Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Serological Transplant Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Serological Transplant Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serological Transplant Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serological Transplant Diagnostics.

The global Serological Transplant Diagnostics market size is projected to grow from US$ 338 million in 2022 to US$ 398.1 million in 2029; it is expected to grow at a CAGR of 2.4% from 2023 to 2029.

Chronic kidney disease increases the risk of cardiovascular disease (CVD) and end-stage kidney renal disease (ESRD). The recent years witnessed a rise in the number of kidney transplantation procedures. The reduction in the average cost of gene sequencing will positively influence the growth of the human leukocyte antigen (HLA) typing market in the kidney transplantation segment. Additionally, the emergence of advanced serological diagnostic technologies will also boost the adoption of kidney transplantation procedures and will aid in serological transplant diagnostics market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Serological Transplant Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation

Segmentation by application
Hospitals, Blood Banks and Transplant Centers
Donor Registries and Research Laboratories

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Immucor
Siemens Healthineers
Ortho Clinical Diagnostics
Thermo Fisher Scientific
Agena Bioscience
AVIOQ
BAG Healthcare
BD
Beckman Coulter
Biogenuix
DIAGAST
Grifols
Hemo bioscience
Institut de Biotechnologies
Lorne Laboratories
MTC Invitro
Quotient Biodiagnostics
Tulip Group

Please note: The report will take approximately 2 business days to prepare and deliver.